Recent Advances in Vaccines and Drugs Against the Ebola Virus / 病毒学报
Chinese Journal of Virology
; (6): 287-292, 2015.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-296286
Biblioteca responsável:
WPRO
ABSTRACT
The Ebola virus belongs to the Filovirus family, which causes Ebola hemorrhagic fever (mortality, 25%-90%). An outbreak of infection by the Ebola virus is sweeping across West Africa, leading to high mortality and worldwide panic. The Ebola virus has caused a serious threat to public health, so intensive scientific studies have been carried out. Several vaccines (e.g., rVSV-ZEBOV, ChAd3-ZEBOV) have been put into clinical trials and antiviral drugs (e.g., TKM-Ebola, ZMAPP) have been administered in the emergency setting to patients infected by the Ebola virus. Here, recent advances in vaccines and drugs against the Ebola virus are reviewed.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Antivirais
/
Fisiologia
/
Virologia
/
Doença pelo Vírus Ebola
/
Vacinas contra Ebola
/
Tratamento Farmacológico
/
Ebolavirus
/
Alergia e Imunologia
/
Genética
Limite:
Animais
/
Humanos
Idioma:
Chinês
Revista:
Chinese Journal of Virology
Ano de publicação:
2015
Tipo de documento:
Artigo